Chinese Journal of Stroke ›› 2015, Vol. 10 ›› Issue (09): 771-777.
Previous Articles Next Articles
Received:
2014-10-11
Online:
2015-09-20
Published:
2015-09-20
李海龙, 毕晓莹
通讯作者:
毕晓莹 bxy616@sina.com
LI Hai-Long, BI Xiao-Ying. . Progress of Researches on the Mechanism of the Role of Nonspecific Inflammation Mediatedby Microglia Activation in the White Matter Demyelination of Vascular Cognitive Impairment[J]. Chinese Journal of Stroke, 2015, 10(09): 771-777.
李海龙, 毕晓莹. 小胶质细胞激活介导非特异性炎症在血管性认知障碍白质脱髓鞘损伤机制中的研究进展[J]. 中国卒中杂志, 2015, 10(09): 771-777.
1 Iadecola C. The pathobiology of vascular dementia[J].Neuron, 2013, 80:844-866.2 Brickman AM, Siedlecki KL, Muraskin J, et al. Whitematter hyperintensities and cognition:testing thereserve hypothesis[J]. Neurobiol Aging, 2011, 32:1588-1598.3 Candelario-Jalil E, Thompson J, Taheri S, et al. Matrixmetalloproteinases are associated with increasedblood-brain barrier opening in vascular cognitiveimpairment[J]. Stroke, 2011, 42:1345-1350.4 Back SA, Kroenke CD, Sherman LS, et al. Whitematter lesions defined by diffusion tensor imaging inolder adults[J]. Ann Neurol, 2011, 70:465-476.5 Fernando MS, Simpson JE, Matthews F, et al.White matter lesions in an unselected cohort of theelderly:molecular pathology suggests origin fromchronic hypoperfusion injury[J]. Stroke, 2006,37:1391-1398.6 Simpson JE, Fernando MS, Clark L, et al. Whitematter lesions in an unselected cohort of theelderly:astrocytic, microglial and oligodendrocyteprecursor cell responses[J]. Neuropathol ApplNeurobiol, 2007, 33:410-419.7 Bai Z, Stamova B, Xu H, et al. Distinctive RNAexpression profiles in blood associated withAlzheimer disease after accounting for white matterhyperintensities[J]. Alzheimer Dis Assoc Disord,2014, 28:226-233.8 Rouhl RP, Damoiseaux JG, Lodder J, et al. Vascularinflammation in cerebral small vessel disease[J].Neurobiol Aging, 2012, 33:1800-1806.9 Gallacher J, Bayer A, Lowe G, et al. Is sticky bloodbad for the brain?:Hemostatic and inflammatorysystems and dementia in the Caerphilly ProspectiveStudy[J]. Arterioscler Thromb Vasc Biol, 2010,30:599-604.10 Perry VH, Nicoll JA, Holmes C. Microglia inneurodegenerative disease[J]. Nat Rev Neurol, 2010,6:193-201.11 Glass CK, Saijo K, Winner B, et al. Mechanismsunderlying inflammation in neurodegeneration[J].Cell, 2010, 140:918-934.12 Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity:uncovering the molecularmechanisms[J]. Nat Rev Neurosci, 2007, 8:57-69.13 Hanisch UK, Kettenmann H. Microglia:activesensor and versatile effector cells in the normal andpathologic brain[J]. Nat Neurosci, 2007, 10:1387-1394.14 Biber K, Neumann H, Inoue K, et al. Neuronal'On' and 'Off' signals control microglia[J]. TrendsNeurosci, 2007, 30:596-602.15 Denes A, Ferenczi S, Halasz J, et al. Role ofCX3CR1(fractalkine receptor) in brain damage andinflammation induced by focal cerebral ischemia inmouse[J]. J Cereb Blood Flow Metab, 2008, 28:1707-1721.16 Cardona AE, Pioro EP, Sasse ME, et al. Control ofmicroglial neurotoxicity by the fractalkine receptor[J].Nat Neurosci, 2006, 9:917-924.17 Corona AW, Huang Y, O'Connor JC, et al. Fractalkinereceptor(CX3CR1) deficiency sensitizes mice to thebehavioral changes induced by lipopolysaccharide[J].J Neuroinflammation, 2010, 7:93.18 Tang Z, Gan Y, Liu Q, et al. CX3CR1 deficiencysuppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke[J]. JNeuroinflammation, 2014, 11:26.19 Deng Y, Lu J, Sivakumar V, et al. Amoeboidmicroglia in the periventricular white matter induceoligodendrocyte damage through expression ofproinflammatory cytokines via MAP kinase signalingpathway in hypoxic neonatal rats[J]. Brain Pathol,2008, 18:387-400.20 Boer K, Troost D, Jansen F, et al. Clinicopathologicaland immunohistochemical findings in an autopsy caseof tuberous sclerosis complex[J]. Neuropathology,2008, 28:577-590.21 Liu Y, Zhao T, Yang Z, et al. CX3CR1 RNAi inhibitshypoxia-induced microglia activation via p38MAPK/PKC pathway[J]. Int J Exp Pathol, 2014, 95:153-157.22 Wolf Y, Yona S, Kim KW, et al. Microglia, seen fromthe CX3CR1 angle[J]. Front Cell Neurosci, 2013, 7:26.23 Okun E, Griffioen KJ, Lathia JD, et al. Toll-likereceptors in neurodegeneration[J]. Brain Res Rev,2009, 59:278-292.24 Song M, Jin J, Lim JE, et al. TLR4 mutation reducesmicroglial activation, increases Abeta deposits andexacerbates cognitive deficits in a mouse model ofAlzheimer's disease[J]. J Neuroinflammation, 2011,8:92.25 Howell OW, Rundle JL, Garg A, et al. Activatedmicroglia mediate axoglial disruption that contributesto axonal injury in multiple sclerosis[J]. J NeuropatholExp Neurol, 2010, 69:1017-1033.26 Caso JR, Pradillo JM, Hurtado O, et al. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening ofexperimental stroke[J]. Stroke, 2008, 39:1314-1320.27 Caso JR, Pradillo JM, Hurtado O, et al. Toll-like receptor 4 is involved in brain damage andinflammation after experimental stroke[J]. Circulation,2007, 115:1599-1608.28 Ock J, Jeong J, Choi WS, et al. Regulation of Toll-likereceptor 4 expression and its signaling by hypoxia incultured microglia[J]. J Neurosci Res, 2007, 85:1989-1995.29 Bell MT, Puskas F, Agoston VA, et al. Toll-like receptor 4-dependent microglial activationmediates spinal cord ischemia-reperfusion injury[J].Circulation, 2013, 128(11 Suppl 1):S152-156.30 Wang Y, He H, Li D, et al. The role of the TLR4signaling pathway in cognitive deficits followingsurgery in aged rats[J]. Mol Med Rep, 2013, 7:1137-1142.31 Brea D, Blanco M, Ramos-Cabrer P, et al. Toll-likereceptors 2 and 4 in ischemic stroke:outcome andtherapeutic values[J]. J Cereb Blood Flow Metab,2011, 31:1424-1431.32 Qiu J, Xu J, Zheng Y, et al. High-mobility group box1 promotes metalloproteinase-9 upregulation throughToll-like receptor 4 after cerebral ischemia[J]. Stroke,2010, 41:2077-2082.33 Li H, Jin M, Lv T, et al. Mechanism of focalcerebral ischemic tolerance in rats with ischemicpreconditioning involves MyD88- and TRIF-dependent pathways[J]. Exp Ther Med, 2013, 6:1375-1379.34 Kuno R, Wang J, Kawanokuchi J, et al. Autocrineactivation of microglia by tumor necrosis factor-alpha[J]. J Neuroimmunol, 2005, 162:89-96.35 Olsson B, Hertze J, Lautner R, et al. Microglialmarkers are elevated in the prodromal phase ofAlzheimer's disease and vascular dementia[J]. JAlzheimers Dis, 2013, 33:45-53.36 Nakazawa T, Nakazawa C, Matsubara A, et al. Tumornecrosis factor-alpha mediates oligodendrocyte deathand delayed retinal ganglion cell loss in a mousemodel of glaucoma[J]. J Neurosci, 2006, 26:12633-12641.37 Li J, Ramenaden ER, Peng J, et al. Tumor necrosisfactor alpha mediates lipopolysaccharide-inducedmicroglial toxicity to developing oligodendrocyteswhen astrocytes are present[J]. J Neurosci, 2008,28:5321-5330.38 Koo JW, Russo SJ, Ferguson D, et al. Nuclear factor-kappaB is a critical mediator of stress-impairedneurogenesis and depressive behavior[J]. Proc NatlAcad Sci USA, 2010, 107:2669-2674.39 Miron VE, Boyd A, Zhao JW, et al. M2 microglia andmacrophages drive oligodendrocyte differentiationduring CNS remyelination[J]. Nat Neurosci, 2013,16:1211-1218.40 Segovia KN, McClure M, Moravec M, et al. Arrestedoligodendrocyte lineage maturation in chronicperinatal white matter injury[J]. Ann Neurol, 2008,63:520-530.41 Miyamoto N, Maki T, Pham LD, et al. Oxidativestress interferes with white matter renewal afterprolonged cerebral hypoperfusion in mice[J]. Stroke,2013, 44:3516-3521.42 Fischer R, Wajant H, Kontermann R, et al.Astrocyte-specific activation of TNFR2 promotesoligodendrocyte maturation by secretion of leukemiainhibitory factor[J]. Glia, 2014, 62:272-283.43 VonDran MW, Singh H, Honeywell JZ, et al. Levels ofBDNF impact oligodendrocyte lineage cells followinga cuprizone lesion[J]. J Neurosci, 2011, 31:14182-14190.44 Cui QL, Fragoso G, Miron VE, et al. Response ofhuman oligodendrocyte progenitors to growth factorsand axon signals[J]. J Neuropathol Exp Neurol, 2010,69:930-944.45 Wang Y, Cao M, Liu A, et al. Changes of inflammatorycytokines and neurotrophins emphasized their rolesin hypoxic-ischemic brain damage[J]. Int J Neurosci,2013, 123:191-195.46 Pang Y, Zheng B, Fan LW, et al. IGF-1 protectsoligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt andinterruption of the mitochondrial apoptotic pathway[J].Glia, 2007, 55:1099-1107.47 Lalancette-Hebert M, Gowing G, Simard A, et al.Selective ablation of proliferating microglial cellsexacerbates ischemic injury in the brain[J]. J Neurosci,2007, 27:2596-2605.48 Mason JL, Suzuki K, Chaplin DD, et al. Interleukin-1beta promotes repair of the CNS[J]. J Neurosci, 2001,21:7046-7052. |
[1] |
LI Yuerong, QIN Xiude, DANG Zhaohui, LU Yunwei, CAI Tiantian, CAI Haobin, BU Fan.
Research Progress of Microglia on Mediating Central Post-Stroke Pain [J]. Chinese Journal of Stroke, 2024, 19(8): 967-972. |
[2] |
WANG Minjie, HAN Cong, DUAN Lian.
Moyamoya Angiopathy and Immune-Related Diseases [J]. Chinese Journal of Stroke, 2024, 19(7): 747-754. |
[3] | LIANG Xiaoxue, GUO Li. Obesity-Related Chronic Inflammation and Cerebro-Metabolic Disease [J]. Chinese Journal of Stroke, 2024, 19(2): 138-144. |
[4] | HAO Dandan, WANG Danyang, LI Li. Study on the Brain Protection of Granulocyte Colony-Stimulating Factor in Stroke after Alcohol Use Disorder [J]. Chinese Journal of Stroke, 2024, 19(10): 1170-1179. |
[5] | JU Jiajun, WANG Xinxin, HANG Lihua. Research Progress on the Correlation between Neuroinflammation and Brain Iron Metabolism after Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(10): 1205-1214. |
[6] | JIAO Junping, BAO Junqiang, SHI Huimin, GAO Chao, TIAN Shujuan. LACC1 Aggravated Ischemia Reperfusion by Phosphorylate AMP-activated Protein Kinase/Nucleotide-binding Oligomerization Domain-like Receptor Protein 3 in Cerebral Infarction [J]. Chinese Journal of Stroke, 2023, 18(9): 1006-1013. |
[7] | CHENG Anqi, LIU Caiyan, XU Weihai. Advances in Clinical Research of Neuropsychology and Imaging of Vascular Cognitive Impairment [J]. Chinese Journal of Stroke, 2023, 18(11): 1222-1227. |
[8] | KONG Demin, ZOU Wei. Impact of Microglia Polarization and Related Inflammatory Signaling Pathways on Secondary Brain Injury after Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2023, 18(11): 1315-1323. |
[9] | SUN Xiaowei, JING Yunnan. Retrospective Study of Ginaton in the Treatment of Vascular Cognitive Impairment [J]. Chinese Journal of Stroke, 2023, 18(10): 1154-1159. |
[10] |
ZHANG Xinyi, CHEN Chuxin, DONG Jianyu, ZHANG Ning, WANG Chunxue.
Sleep Disorder and Non-drug Therapy in Patients with Vascular Cognitive Impairment
[J]. Chinese Journal of Stroke, 2023, 18(05): 601-609.
|
[11] | SI Qianqian, CHENG Anqi, FAN Xiaoyuan, ZHANG Xiaoqian, LI Mingli, FENG Feng, LIU Caiyan, XU Weihai. Relationship between Intracranial Atherosclerotic Stenosis and Cognition [J]. Chinese Journal of Stroke, 2023, 18(04): 418-427. |
[12] |
LI Yanran, CHENG Si, ZHAO Manman, LI Hao, WANG Yongjun.
Mosaic Loss of Y Chromosome and Cardio-and Cerebrovascular Diseases
[J]. Chinese Journal of Stroke, 2023, 18(02): 175-179.
|
[13] | GONG Yutian, LI Jiejie. Advances in the Relationship between IL-6 and Atherosclerotic Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(09): 1022-1026. |
[14] | DONG Wen, JIANG Mingyu, CHEN Wentao, LIU Wenqian, CHEN Qingfang, ZHAO Shunying, YE Weizhen, WEN Shaohong, LIU Xiangrong. The Effect of Dual Antiplatelet Therapy with Aspirin and Clopidogrel on Inflammatory Response in Bone Marrow and Brain after Cerebral Ischemia Injury in Mice [J]. Chinese Journal of Stroke, 2022, 17(06): 605-610. |
[15] | WENG Jiaxu, QIU Xin, LI Zixiao. Progress of the Relationship between TET2 Mutation Related Clonal Hematopoiesis of Indeterminate Potential and Stroke [J]. Chinese Journal of Stroke, 2022, 17(04): 413-417. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||